Literature DB >> 16254805

Becatecarin (Helsinn Healthcare).

Gordon W Rewcastle1.   

Abstract

Helsinn Healthcare SA is developing becatecarin, a topoisomerase II inhibitor for the potential intravenous treatment of cancer.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16254805

Source DB:  PubMed          Journal:  IDrugs        ISSN： 1369-7056


  1 in total

1.  Precursor-Directed Generation of Indolocarbazoles with Topoisomerase IIα Inhibitory Activity.

Authors:  Cong Wang; Adeep Monger; Liping Wang; Peng Fu; Pawinee Piyachaturawat; Arthit Chairoungdua; Weiming Zhu
Journal:  Mar Drugs       Date:  2018-05-17       Impact factor: 5.118
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.